Top Two Hot of the Day: Biogen Inc. (NASDAQ:BIIB), Xylem Inc. (NYSE:XYL)

Biogen Inc. (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB) closed at $334.25 on the last trading session with an increase of 0.75%, whereas, it previously closed at $331.76. The company has a market capitalization of $60.05 Billion. The company traded shares of 1.27 Million on the trading day while its three month average volume stands at 1.86 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Biogen Inc. (NASDAQ:BIIB) produced diluted EPS of 28.24. The EPS estimate for next year as estimated by analysts is at 32.34 while EPS for next quarter is estimated at 7.84. Earnings per Share growth for this year is reported at 44.8, while the analysts estimated the EPS growth for next year at 32.34% and Earnings growth for next 5 years stands at 2.6% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 20.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Biogen Inc. (NASDAQ:BIIB) is at 11.84 while the forward p/e is at 10.34. The P/S or Price to Sales ratio of Biogen Inc. (NASDAQ:BIIB) stands at 4.22 and Price to Book or P/B for the most recent quarter stands at 4.45. The Price to Free Cash Flow ratio or P/FCF is reported at 9.15. The quick ratio and the current ratio of Biogen Inc. (NASDAQ:BIIB) are reported at 1.6 and 1.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Biogen Inc. (NASDAQ:BIIB) stands at 21.9, 43.5 and 30.5 respectively

The trailing twelve month Revenue of Biogen Inc. (NASDAQ:BIIB) is reported at 14.23 Billion with income of 5.42 Billion. The outstanding shares of Biogen Inc. (NASDAQ:BIIB) are 179.66 Million. The institutional Ownership of the shares of 90.8 stands at 0.80%, this figure is decreased -1.34 in the last six months. The insider ownership for the shares of Biogen Inc. (NASDAQ:BIIB) is ticked at 0.62%, the figure is plummeted -0.09% in the last six months.

Some other important financial aspects to be discussed here for Biogen Inc. (NASDAQ:BIIB) is the Mean Target Price estimated by the analysts which stands at 327.3. The 52 week high of Biogen Inc. (NASDAQ:BIIB) is placed at 374.99 and 52 week low is standing at 215.77.

Performance wise the shares of Biogen Inc. (NASDAQ:BIIB) fell down -0.89% for the week, it also rise 11.8% for the monthly performance, while for the quarter it went down 14.7%. The shares increase 47.43% for the half year and flew up for the Year-To-Date performance. The shares of Biogen Inc. (NASDAQ:BIIB) grew 3.95% for the yearly performance.

Xylem Inc. (NYSE:XYL)

Xylem Inc. (NYSE:XYL) closed at $87.05 on the last trading session with an decrease of -2.33%, whereas, it previously closed at $89.13. The company has a market capitalization of $15.68 Billion. The company traded shares of 2.1 Million on the trading day while its three month average volume stands at 1.09 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Xylem Inc. (NYSE:XYL) produced diluted EPS of 2.21. The EPS estimate for next year as estimated by analysts is at 3.55 while EPS for next quarter is estimated at 0.46. Earnings per Share growth for this year is reported at 47.5, while the analysts estimated the EPS growth for next year at 3.55% and Earnings growth for next 5 years stands at 11.31% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 20.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Xylem Inc. (NYSE:XYL) is at 39.35 while the forward p/e is at 24.51. The P/S or Price to Sales ratio of Xylem Inc. (NYSE:XYL) stands at 2.99 and Price to Book or P/B for the most recent quarter stands at 5.43. The Price to Free Cash Flow ratio or P/FCF is reported at 90.62. The quick ratio and the current ratio of Xylem Inc. (NYSE:XYL) are reported at 1.2 and 1.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Xylem Inc. (NYSE:XYL) stands at 7.7, 20.2 and 12.3 respectively

The trailing twelve month Revenue of Xylem Inc. (NYSE:XYL) is reported at 5.25 Billion with income of 401 Million. The outstanding shares of Xylem Inc. (NYSE:XYL) are 180.1 Million. The institutional Ownership of the shares of 93.1 stands at 0.80%, this figure is increased 0.68 in the last six months. The insider ownership for the shares of Xylem Inc. (NYSE:XYL) is ticked at 0.1%, the figure is plummeted -21.31% in the last six months.

Some other important financial aspects to be discussed here for Xylem Inc. (NYSE:XYL) is the Mean Target Price estimated by the analysts which stands at 80.75. The 52 week high of Xylem Inc. (NYSE:XYL) is placed at 89.34 and 52 week low is standing at 72.15.

Performance wise the shares of Xylem Inc. (NYSE:XYL) rose up 4.73% for the week, it also rise 6.98% for the monthly performance, while for the quarter it went down 13.58%. The shares increase 16.25% for the half year and flew up for the Year-To-Date performance. The shares of Xylem Inc. (NYSE:XYL) grew 19.77% for the yearly performance.